Created
February 8, 2022 20:09
-
-
Save philiptzou/43ea52b1a855cfc60145c2ba808e5a23 to your computer and use it in GitHub Desktop.
This file contains bidirectional Unicode text that may be interpreted or compiled differently than what appears below. To review, open the file in an editor that reveals hidden Unicode characters.
Learn more about bidirectional Unicode characters
ref_name | subject_name | subject_species | birth_year | immune_status | num_subjects | note | |
---|---|---|---|---|---|---|---|
Bronstein21 | Patient 1 | Human | 1953 | 1 | Immunocompromised | ||
Sabin21 | P3 | Human | 1 | Household case report | |||
Kemp21 | Septuagenarian male | Human | 1945 | 1 | prolonged infection, d1 | ||
Jensen21 | Patient 6 | Human | 1955 | 1 | prolonged infection, d20 | ||
Baang21 | Patient | Human | 1 | Immunocompromised | |||
Sabin21 | P4 | Human | 1 | Household case report | |||
Choudhary21 | ACTIV-2/A5401 trial | Human | 111 | ||||
Kemp21 | Septuagenarian male | Human | 1945 | 1 | prolonged infection, d55 | ||
Sabin21 | P1 | Human | 1 | Household case report | |||
Copin21 | Non-hospitalized high dose patients | Human | 238 | ≥2 samples from ≥1 subject (uncertain how many samples sequenced per person) | |||
Jensen21 | Patient 3 | Human | 1958 | 1 | prolonged infection, d81 | ||
Sabin21 | P5 | Human | 1 | Household case report | |||
Choi20 | MA-JLL | Human | 1975 | 1 | prolonged infection, T0d25 | ||
Choi20 | MA-JLL | Human | 1975 | 1 | prolonged infection, T1d81 | ||
Kemp21 | Septuagenarian male | Human | 1945 | 1 | prolonged infection, d93 | ||
Choi20 | MA-JLL | Human | 1975 | 1 | prolonged infection, T2d130 | ||
Jensen21 | Patient 1 | Human | 1948 | 1 | prolonged infection, d12 | ||
Copin21 | REGN10933 treatment low dose hamsters | Hamster | 5 | RBD/Treatment | |||
Copin21 | Non-hospitalized low dose patients | Human | 247 | ≥2 samples from ≥1 subject (uncertain how many samples sequenced per person) | |||
Truffot21 | Patient | Human | 1949 | 1 | Immunocompromised | ||
Jensen21 | Patient 4 | Human | 1952 | 1 | prolonged infection, d19 | ||
Sabin21 | P2 | Human | 1 | Household case report | |||
Choi20 | MA-JLL | Human | 1975 | 1 | prolonged infection, T2d128 | ||
Peiffer-Smadja21 | Patient 5 | Human | 1957 | 1 | BAM treated | ||
Jensen21 | Patient 1 | Human | 1948 | 1 | prolonged infection, d14 | ||
Guigon21 | Patient | Human | 1958 | 1 | Immunocompromised | ||
Kemp21 | Septuagenarian male | Human | 1945 | 1 | prolonged infection, d100 | ||
Focosi21b | VA-CF | Human | 1948 | 1 | Tested positive in Apr 2021 | ||
Williamson21 | Patient | Human | 1940 | 1 | Immunocompromised | ||
Weigang21 | BW-FR | Human | 1962 | 1 | Prolonged infection | ||
Copin21 | Placebo prevention hamsters | Hamster | 5 | RBD/Prevention | |||
Kemp21 | Septuagenarian male | Human | 1945 | 1 | prolonged infection, d95 | ||
Sabin21 | P6 | Human | 1 | Household case report | |||
Kemp21 | Septuagenarian male | Human | 1945 | 1 | prolonged infection, d89 | ||
Chen21b | Patient_TA | Human | 1965 | 1 | Immunocompromised | ||
Peiffer-Smadja21 | Patient 2 | Human | 1986 | 1 | BAM treated | ||
Choi20 | MA-JLL | Human | 1975 | 1 | prolonged infection, T3d152 | ||
Copin21 | Placebo treatment hamsters | Hamster | 5 | RBD/Treatment | |||
Kemp21 | Septuagenarian male | Human | 1945 | 1 | prolonged infection, d54 | ||
Copin21 | REGEN-COV treatment high dose hamsters | Hamster | 5 | RBD/Treatment | |||
Bazykin21 | Patient S | Human | 1 | Immunocompromised | |||
Bronstein21 | Patient 2 | Human | 1988 | 1 | Immunocompromised | ||
Jensen21 | Patient 5 | Human | 1952 | 1 | prolonged infection, d51 | ||
Copin21 | Hospitalized high dose patients | Human | 93 | ≥2 samples from ≥1 subject (uncertain how many samples sequenced per person) | |||
Peiffer-Smadja21 | Patient 1 | Human | 1934 | 1 | BAM treated | ||
Copin21 | Non-hospitalized placebo patients | Human | 243 | ≥2 samples from ≥1 subject (uncertain how many samples sequenced per person) | |||
Kemp21 | Septuagenarian male | Human | 1945 | 1 | prolonged infection, d82 | ||
Copin21 | REGN10987 prevention high dose hamsters | Hamster | 5 | RBD/Prevention | |||
Copin21 | REGN10933 prevention high dose hamsters | Hamster | 5 | RBD/Prevention | |||
Kemp21 | Septuagenarian male | Human | 1945 | 1 | prolonged infection, d50 | ||
Kemp21 | Septuagenarian male | Human | 1945 | 1 | prolonged infection, d66 | ||
Kemp21 | Septuagenarian male | Human | 1945 | 1 | prolonged infection, d98 | ||
Copin21 | Hospitalized placebo patients | Human | 91 | ≥2 samples from ≥1 subject (uncertain how many samples sequenced per person) | |||
Peiffer-Smadja21 | Patient 3 | Human | 1960 | 1 | BAM treated | ||
Copin21 | REGEN-COV prevention low dose hamsters | Hamster | 5 | RBD/Prevention | |||
Stanevich21 | Patient S | Human | 1973 | 1 | prolonged infection | ||
Copin21 | REGEN-COV treatment low dose hamsters | Hamster | 5 | RBD/Treatment | |||
Kemp21 | Septuagenarian male | Human | 1945 | 1 | prolonged infection, d99 | ||
Choi20 | MA-JLL | Human | 1975 | 1 | prolonged infection, T0d18 | ||
Copin21 | Hospitalized low dose patients | Human | 88 | ≥2 samples from ≥1 subject (uncertain how many samples sequenced per person) | |||
Jensen21 | Patient 5 | Human | 1952 | 1 | prolonged infection, d52 | ||
Choi20 | MA-JLL | Human | 1975 | 1 | prolonged infection, T3d143 | ||
Jensen21 | Patient 2 | Human | 1978 | 1 | prolonged infection, d9 | ||
Hensley21 | Patient | Human | 1948 | 1 | Immunocompromised | ||
Jensen21 | Patient 5 | Human | 1952 | 1 | prolonged infection, d49 | ||
Copin21 | REGN10933 prevention low dose hamsters | Hamster | 5 | RBD/Prevention | |||
Copin21 | REGN10933 treatment high dose hamsters | Hamster | 5 | RBD/Treatment | |||
Kemp21 | Septuagenarian male | Human | 1945 | 1 | prolonged infection, d41 | ||
Copin21 | REGN10987 prevention low dose hamsters | Hamster | 5 | RBD/Prevention | |||
Kemp21 | Septuagenarian male | Human | 1945 | 1 | prolonged infection, d56 | ||
Kemp21 | Septuagenarian male | Human | 1945 | 1 | prolonged infection, d45 | ||
Choi20 | MA-JLL | Human | 1975 | 1 | prolonged infection, T1d75 | ||
Copin21 | REGN10987 treatment low dose hamsters | Hamster | 5 | RBD/Treatment | |||
Copin21 | REGN10987 treatment high dose hamsters | Hamster | 5 | RBD/Treatment | |||
Jensen21 | Patient 1 | Human | 1948 | 1 | prolonged infection, d16 | ||
Peiffer-Smadja21 | Patient 6 | Human | 1955 | 1 | BAM treated | ||
Copin21 | REGEN-COV prevention high dose hamsters | Hamster | 5 | RBD/Prevention | |||
Kemp21 | Septuagenarian male | Human | 1945 | 1 | prolonged infection, d37 | ||
Karim21 | Patient | Human | 1991 | 1 | Immunocompromised | ||
Peiffer-Smadja21 | Patient 4 | Human | 1924 | 1 | BAM treated | ||
Kemp21 | Septuagenarian male | Human | 1945 | 1 | prolonged infection, d57 | ||
Avanzato20 | WA-RML | Human | 1949 | 1 | prolonged infection | ||
Lohr21 | Patient | Human | 1966 | 1 | Immunocompromised | ||
Khatamzas21 | Patient A | Human | 1947 | 1 | Prolonged infection | ||
Kemp21 | Septuagenarian male | Human | 1945 | 1 | prolonged infection, d101 | ||
Choi20 | MA-JLL | Human | 1975 | 1 | prolonged infection, T3d146 | ||
Kemp21 | Septuagenarian male | Human | 1945 | 1 | prolonged infection, d86 | ||
Nussenblatt21 | Patient | Human | 1 | B cell depletion | |||
Borges21 | Patient | Human | 1960 | 1 | Immunocompromised |
Sign up for free
to join this conversation on GitHub.
Already have an account?
Sign in to comment